Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Antonio Sgadari, assistant professor,
  2. Giovanni Gambassi (giovanni_gambassi@rm.unicatt.it), associate professor of medicine,
  3. Claudio Pedone, assistant professor,
  4. Graziano Onder, assistant professor
  1. Centro di Medicina dell'Invecchiamento Università Cattolica del Sacro Cuore Rome, Italy
  2. Center for Gerontology and Health Care Research, Brown University School of Medicine, Providence, RI, USA
  3. Sticht Center on Aging, Wake Forest University Medical School, Winston, Salem, NC, USA

    EDITOR—In reporting their case-control study with 245 incident hip fractures, Pierfitte et al conclude that use of benzodiazepines does not confer any added risk.1 Unusually, plasma benzodiazepine concentrations were measured.

    Fracture is considered to be the result of either an increased tendency to fall or an increased tendency to fracture, or both, so it would have been appropriate to gather information on history of fall. Use of benzodiazepines may lead to hip fracture by increasing the risk of falling and by affecting …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular